Drugs for Relapse Prevention of Alcoholism

1. History of prevention of relapse
Griffith Edwards

2. How to measure relapse in animals
Rainer Spanagel

3. How to measure relapse in humans
Henry R. Kranzler, Howard Tennen

4. Disulfiram (Antabuse®): the first medication to stop drinking
Dieter Ladewig, Ulrich Bardeleben

5. Naltrexone: preclinical data
Michael S. Cowen

6. Naltrexone: clinical data
Charles P. O’Brien, Helen M. Pettinati, David W. Oslin

7. Acamprosate: preclinical data
Philippe Witte, Daniel Bachteler, Rainer Spanagel

8. Acamprosate: clinical data
Karl F. Mann

9. Serotonergic compounds: preclinical data
Anh Dzung Lê, Douglas R. Funk

10. Serotonergic compounds: clinical data
Bankole A. Johnson

11. Opioidergic compounds: preclinical data
Petri Hyytiä

12. Second generation opioidergic compounds: clinical data
John David Sinclair

13. Dopaminergic compounds: preclinical data
Friedbert Weiss

14. Dopaminergic compounds: clinical data
Gerhard A. Wiesbeck

15. Baclofen: preclinical data
Mauro A.M. Carai, Roberta Agabio, Giovanni Addolorato, Gian L. Gessa, Giancarlo Colombo

16. Baclofen: clinical data
Giovanni Addolorato, Ludovico Abenavoli, Lorenzo Leggio, Giosuè DeLorenzi, Anna Ferrulli, Fabio Caputo, Roberta Agabio, Gian Luigi Gessa, Giancarlo Colombo, Giovanni Gasbarrini

17. Cannabinoid receptor antagonists: a perspective
Mauro A.M. Carai, Carla Lobina, Gian Luigi Gessa, Giancarlo Colombo

18. Neuropeptide Y antagonists: a perspective
Markus Heilig, Todd E. Thiele

19. Glutamatergic compounds: a perspective
Daniel Bachteler, Rainer Spanagel

20. Future perspectives on relapse prevention
Rainer Spanagel, Karl F. Mann

DRM-restrictions

Printing: not available
Clipboard copying: not available

Nyckelord: TECHNOLOGY & ENGINEERING / Biomedical TEC059000